Antiplatelet therapy. The Aspirin for Asymptomatic
Atherosclerosis Trial55 randomized 3350 patients with
asymptomatic PAD to treatment with enteric-coated aspirin
(100 mg) or placebo. During 8 years of follow-up, no difference in vascular event rates was noted. However, this trial
used an epidemiologic method of ABI determination in
which the lower of the ankle pressures was used to calculate
the ABI